Erratum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy (Oncotarget. (2020) 11 (4195–4200) DOI: 10.18632/oncotarget.27793)

Document Type

Article

Publication Title

Oncotarget

Abstract

This article has an addendum: The patient has previously consented to publication of de-identified findings.

First Page

1215

DOI

10.18632/oncotarget.28296

Publication Date

1-1-2022

This document is currently not available here.

Share

COinS